LIPK and lung adenocarcinoma: As an important regulator of triglyceride hydrolysis and fatty acid metabolism, the lipid metabolism-related enzyme LIPK (Lipase K) may disrupt lipid homeostasis, affecting the energy supply, membrane structure remodeling, and signal transduction of tumor cells, thereby driving the progression of lung adenocarcinoma (20–22).